Correction to Lancet Oncol 2018; 19: 580-81
- PMID: 29726387
- DOI: 10.1016/S1470-2045(18)30285-7
Correction to Lancet Oncol 2018; 19: 580-81
Erratum for
-
Is there any interest in a new BRAF-MEK inhibitor combination in melanoma?Lancet Oncol. 2018 May;19(5):580-581. doi: 10.1016/S1470-2045(18)30161-X. Epub 2018 Mar 21. Lancet Oncol. 2018. PMID: 29573940 No abstract available.
Similar articles
-
Correction to Lancet Oncol 2018; 19: 295-309.Lancet Oncol. 2018 Apr;19(4):e184. doi: 10.1016/S1470-2045(18)30212-2. Lancet Oncol. 2018. PMID: 29611526 Free PMC article. No abstract available.
-
Correction to Lancet Oncol 2017; 18: 1221-37.Lancet Oncol. 2018 Apr;19(4):e184. doi: 10.1016/S1470-2045(18)30211-0. Lancet Oncol. 2018. PMID: 29611524 No abstract available.
-
Correction to Lancet Oncol 2018; 19: 434-36.Lancet Oncol. 2018 Apr;19(4):e184. doi: 10.1016/S1470-2045(18)30215-8. Lancet Oncol. 2018. PMID: 29611523 No abstract available.
-
Correction to Lancet Oncol 2013; 14: 1067-76.Lancet Oncol. 2018 Apr;19(4):e184. doi: 10.1016/S1470-2045(18)30214-6. Lancet Oncol. 2018. PMID: 29611522 No abstract available.
-
Correction to Lancet Oncol 2018; 19: 474-85.Lancet Oncol. 2018 Apr;19(4):e184. doi: 10.1016/S1470-2045(18)30213-4. Lancet Oncol. 2018. PMID: 29611521 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources